HomeXLO • NASDAQ
add
Xilio Therapeutics Inc
Previous close
$0.68
Day range
$0.67 - $0.74
Year range
$0.62 - $1.70
Market cap
36.25M USD
Avg Volume
2.26M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 2.93M | — |
Operating expense | 16.78M | 1.46% |
Net income | -13.26M | 22.89% |
Net profit margin | -452.73 | — |
Earnings per share | — | — |
EBITDA | -13.35M | 17.04% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 89.07M | 162.13% |
Total assets | 103.72M | 25.55% |
Total liabilities | 93.02M | 63.63% |
Total equity | 10.70M | — |
Shares outstanding | 51.78M | — |
Price to book | 3.23 | — |
Return on assets | -39.62% | — |
Return on capital | -156.32% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -13.26M | 22.89% |
Cash from operations | 28.98M | 375.93% |
Cash from investing | -22.00K | — |
Cash from financing | 4.83M | 406.50% |
Net change in cash | 33.79M | 453.88% |
Free cash flow | 14.51M | 169.36% |
About
Founded
2016
Headquarters
Website
Employees
64
